[Congressional Record Volume 168, Number 158 (Thursday, September 29, 2022)]
[Senate]
[Page S5896]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
SA 6364. Mr. JOHNSON submitted an amendment intended to be proposed
to amendment SA 5499 submitted by Mr. Reed (for himself and Mr. Inhofe)
and intended to be proposed to the bill H.R. 7900, to authorize
appropriations for fiscal year 2023 for military activities of the
Department of Defense, for military construction, and for defense
activities of the Department of Energy, to prescribe military personnel
strengths for such fiscal year, and for other purposes; which was
ordered to lie on the table; as follows:
At the end of subtitle C of title VII, add the following:
SEC. 753. USE OF CERTAIN DOMESTICALLY PRODUCED MEDICAL
ISOTOPES BY DEPARTMENT OF DEFENSE AND
DEPARTMENT OF VETERANS AFFAIRS.
(a) Increased Use.--Beginning not later than September 30,
2023, the Secretary of Defense and the Secretary of Veterans
Affairs shall take steps to increase the use of technetium
99m patient doses procured from domestically manufactured
molybdenum 99 (including by developing a plan to increase the
use of technetium 99m patient doses procured from
domestically manufactured molybdenum 99) only if such
increase does not result in a cost increase compared to the
competitive market.
(b) Report.--Not later than September 30, 2023, and on an
annual basis thereafter until September 30, 2028, the
Secretary of Defense and the Secretary of Veterans Affairs
shall jointly submit to the Committee on Appropriations of
the Senate and the Committee on Appropriations of the House
of Representatives a report on the percentage of technetium
99m patient doses procured by each Secretary from
domestically manufactured molybdenum 99 during the one-year
period preceding the date of the report.
______